Funding cuts in medical research pose a significant threat to the integrity and effectiveness of clinical studies aimed at enhancing patient safety in medical research.As federal research grants dwindle, the ability of institutions like Harvard to uphold necessary IRB oversight is severely compromised, leading to a rippling effect across the entire research landscape.